Inventor · disambiguated record
Olivier Mirguet
Also filed as: MIRGUET OLIVIER
15 granted patents·9 pending applications·73 citations·filing 2010–2024
89Inventor score
Files withGLAXOSMITHKLINE IP DEV LTD8GLAXOSMITHKLINE LLC5BOUILLOT ANNE MARIE JEANNE2MIRGUET OLIVIER2BAILEY JAMES1
Top patents by PatentIndex Score
24 records- 0191US8557984B2Imidazo [4, 5-C] quinoline derivatives as bromodomain inhibitorsBOUILLOT ANNE MARIE JEANNE·Filed 2010·Granted Oct 15, 2013·50 cites·17 claims
- 0287US9737505B2Prodrug of 1,1′-(1,6-dioxo-1,6-hexanediyl)bis-D-prolineGLAXOSMITHKLINE IP DEV LTD·Filed 2015·Granted Aug 22, 2017·4 cites·16 claims
- 0387US9102677B2Benzodiazepine bromodomain inhibitorBAILEY JAMES·Filed 2010·Granted Aug 11, 2015·14 cites·10 claims
- 0478US10246447B23-(6-chloro-3-oxo-3,4-dihydro-(2H)-1,4-benzoxazin-4-yl) propanoic acid derivatives and their use as KMO inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Apr 2, 2019·2 cites·8 claims
- 0577US12459906B23-(5-chloro-2-oxobenzo[d]oxazol-3(2H)-yl) propanoic acid derivatives as KMO inhibitorsDR FALK PHARMA GMBH·Filed 2022·Granted Nov 4, 2025·0 cites·18 claims
- 0674US9873686B2Prodrug of 1,1′-(1,6-dioxo -1,6-hexanediyl)bis-D-prolineGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Granted Jan 23, 2018·1 cites·2 claims
- 0770US9701668B2Prodrug of 1,1′-(1,6-dioxo-1,6-hexanediyl)bis-D-prolineGLAXOSMITHKLINE IP DEV LTD·Filed 2015·Granted Jul 11, 2017·1 cites·22 claims
- 0865US11352334B23-(5-chloro-2-oxobenzo[d]oxazol-3(2H)-yl) propanoic acid derivatives as KMO inhibitorsUNIV COURT UNIV OF EDINBURGH·Filed 2019·Granted Jun 7, 2022·0 cites·7 claims
- 0965US9023842B2Benzodiazepine bromodomain inhibitorGOSMINI ROMAIN LUC MARIE·Filed 2010·Granted May 5, 2015·1 cites·7 claims
- 1063US2024285614A1Phenol ribonucleotide reductase (rnr) inhibitors and uses thereofBOUNDLESS BIO INC·Filed 2024·Application pending·0 cites
- 1159US10597385B2Prodrug of 1,1′-(1,6-dioxo-1,6-hexanediyl)bis-D-prolineGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Granted Mar 24, 2020·0 cites·4 claims
- 1258US10611756B2Method of treating pancreatitis using 1,4-benzoxazine derivativesGLAXOSMITHKLINE IP DEV LTD·Filed 2019·Granted Apr 7, 2020·0 cites·11 claims
- 1355US2016318884A13-(5-chloro-2-oxobenzo[d]oxazol-3(2h)-yl) propanoic acid derivatives as kmo inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2014·Application pending·0 cites
- 1451US9598420B2Benzodiazepine bromodomain inhibitorGLAXOSMITHKLINE LLC·Filed 2015·Granted Mar 21, 2017·0 cites·12 claims
- 1551US2017197972A1Benzodiazepine bromodomain inhibitorGLAXOSMITHKLINE LLC·Filed 2017·Application pending·0 cites
- 1651US2017145021A1Novel compoundsGLAXOSMITHKLINE LLC·Filed 2017·Application pending·0 cites
- 1746US10328052B2D-proline derivatives as SAP depleting agentGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Jun 25, 2019·0 cites·20 claims
- 1846US2015210706A1Benzodiazepine Bromodomain InhibitorGLAXOSMITHKLINE LLC·Filed 2015·Application pending·0 cites
- 1945US9855260B2Quinolinone derivativesGLAXOSMITHKLINE LLC·Filed 2015·Granted Jan 2, 2018·0 cites·6 claims
- 2040US9061998B2Quinolinone derivativesDAUGAN ALAIN CLAUDE-MARIE·Filed 2012·Granted Jun 23, 2015·0 cites·13 claims
- 2137US2013345243A11h-pyrollo[3,2-d]pyrimidinedione derivativesBOUILLOT ANNE MARIE JEANNE·Filed 2012·Application pending·0 cites
- 2237US2013053407A1Pyrrolo [3,2-d] pyrimidin-3-yl derivatives used as activators of ampkMIRGUET OLIVIER·Filed 2011·Application pending·0 cites
- 2335US2012172333A1Pyrrolo-pyridine derivatives as activators of ampkMIRGUET OLIVIER·Filed 2010·Application pending·0 cites
- 2434US2012202799A1Condensed Azepine Derivatives As Bromodomain InhibitorsCROWE MIRIAM·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →